As part of your cancer care plan, your physician has ordered molecular testing from Caris Life Sciences in order to better understand your tumor’s biomarkers and help identify changes that control cell growth. Results from this test may help guide your personal treatment plan. In order to begin testing, patient consent for molecular profiling is required. Please complete the electronic consent form by clicking the button below.
Choose the appropriate state and language consent form below and return to Caris. Email completed form to CustomerSupport@CarisLS.com, or fax to 866-479-4925.